GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Slc22a12 | affects response to substance | ISO | SLC22A12 (Homo sapiens) | 6480464 | CTD | SLC22A12 protein affects the susceptibility to Losartan | PMID:18670416 | Slc22a12 | decreases activity | ISO | SLC22A12 (Homo sapiens) | 6480464 | CTD | Losartan results in decreased activity of SLC22A12 protein | PMID:20486468 | Slc22a12 | decreases expression | ISO | SLC22A12 (Homo sapiens) | 6480464 | CTD | Losartan results in decreased expression of SLC22A12 mRNA | PMID:20486468 | Slc22a12 | multiple interactions | ISO | SLC22A12 (Homo sapiens) | 6480464 | CTD | [Losartan results in decreased activity of SLC22A12 protein] which results in decreased abundance of Uric Acid | PMID:18670416 | |
Go Back to source page | Continue to Ontology report |